Drug Eluting Stents - A Combination of Drug, Polymer and Metal
UPDATE - Due to overwhelming demand, registration is now closed. We apologize for the inconvenience.
The application of drug-eluting stent (DES) in interventional cardiology highlights the recent development in drug-device combination product. The selection of the polymer and the drug and the understanding of the interaction between the polymer carrier, the drug, metal stent and delivery catheter play the critical role in designing and developing such product. This presentation will also discuss the regulatory impact of the ever-increasing convergence of pharmaceutical and medical devices.
Dr. Nadine Ding is currently an R&D Fellow with Abbott Vascular in Santa Clara, CA, formerly Guidant Corporation. She was the design leader of the world’s number one selling Xience V drug eluting stent. Dr. Ding is a pioneer in DES research and development and holds 39 US patents in the field, among which are several highly publicized ‘Ding’ patents in the heart of legal battle between several companies. Dr. Ding started her professional carrier with Rohm and Hass on pesticide research and analytical method development. In 1993, she joined Schneider Inc, a Hospital Product Division of Pfizer, which was later acquired by Boston Scientific. She joined Guidant in 2000. Dr. Ding received her PhD degree from the University of Southern California in Chemistry with emphasis on polymer science.
Thursday, March 19
Michael's Restaurant at Shoreline Park
2960 N Shoreline Blvd
Mountain View, CA 94043
6 PM social hour
7 PM dinner
8 PM lecture
$30 with advance registration
Half price for students, retired, and unemployed. (late fee still applies, if applicable)
Free if you attend just the lecture at 8PM. (but please let us know for headcount)
$40 after registration deadline, if possible -- please contact us to inquire.
we accept cash or checks, but are unable to accept payment by credit card at this time. You may pay at the door.
Please register on the web page http://www.ggpf.org/ or contact:
email: syed.askari - at- gmail.com
Deadline for registration:
5 PM, Wednesday, March 18 Registration is now closed.
You should receive confirmation of your registration; if not, please contact us again.